I've been looking for a narrative that helps expla
Post# of 86949
(Total Views: 895)
Posted On: 12/20/2021 11:55:12 AM
I've been looking for a narrative that helps explain the waiting. I'm wondering if this is it.
We know Kismet Impact Capital is involved. We know doc.is on the board as an advisor and that Zach Stadnyk is as well. The closing of the funding round from Impact was Dec 15 and as previously mentioned they target Q1 2022 as the timing for rolling out their investment product. All applications are to be forwarded to Mr Stadnyk. Zach had a specialization in corporate finance.
I believe that Kismet is functioning as a kind of private venture capital for UNVC - like a venture capital etf. This explains the 4c that was released Oct 22. The shares in the 4C were sold at 8 cents. The share price was at 6c and increased to a maximum of 8c has not been back over 8c since then. On Oct 22 volumes were in the 4 millions indicating selling by institutions or by doc I'm assuming and we all assumed back then if memory serves. The 4C was for about 22million shares which likely changed hands over the days right around Oct 22 as evidenced by the daily volume... Especially in comparison to now.
Anyhow I was doing research into corporate finance and my best guess is that UNVC is likely at the stage where we need Mezzanine Financing. Mezzanine financing is not debt but more like equity and is often secured with shares. The financing repayment options are often due at the end of the loan period and are very flexible.and require little due diligence. It is a cheaper easier way to secure capital fudning to get to a next phase of business development (ie. and acquire clinics for example... Which was already said here) without going to a bank. The shares are likely ... I'm guessing... part of the Mezzanine financing deal.
https://www.investopedia.com/terms/m/mezzaninefinancing.asp
Think about it. Buying into Impact at 25 cents per share and them buying a stock you have option for at 8 cents per share and the stock has been trading at a low of 5 cents since this all.happened. That's a lot of upside, especially when we know the stock is ready for uplist and that there are.profitable.companies like HRI which can be folded in and immediately make a 1.5 billion dollar valuation a reality which is about $3 a share on its own.
https://youtu.be/sd4dOiaTgD4
https://www.investopedia.com/ask/answers/0310...ctured.asp
What I'm saying is that I don't think we have anything to worry about in terms of the if. I believe based on above that the Mezzanine financing terms are based on or tied to the uplist. Therefore this has to happen as part of the loan repayment. And the indication from Impact is that this happens in Q1.
Finally, In terms of the exit for Mezzanine Financing (ie. How do the private lenders get paid back). It is often through IPO or through expected increased earnings. Oh and by the way, Mezzanine financing does not dilute shares and maintains shareholder equity.
Thanks Doc!
Ps. Remember I am a healthcare worker so thisn isnt my area of expertise. But I hope
... At the very least... this helps a bit and that the links are useful.
We know Kismet Impact Capital is involved. We know doc.is on the board as an advisor and that Zach Stadnyk is as well. The closing of the funding round from Impact was Dec 15 and as previously mentioned they target Q1 2022 as the timing for rolling out their investment product. All applications are to be forwarded to Mr Stadnyk. Zach had a specialization in corporate finance.
I believe that Kismet is functioning as a kind of private venture capital for UNVC - like a venture capital etf. This explains the 4c that was released Oct 22. The shares in the 4C were sold at 8 cents. The share price was at 6c and increased to a maximum of 8c has not been back over 8c since then. On Oct 22 volumes were in the 4 millions indicating selling by institutions or by doc I'm assuming and we all assumed back then if memory serves. The 4C was for about 22million shares which likely changed hands over the days right around Oct 22 as evidenced by the daily volume... Especially in comparison to now.
Anyhow I was doing research into corporate finance and my best guess is that UNVC is likely at the stage where we need Mezzanine Financing. Mezzanine financing is not debt but more like equity and is often secured with shares. The financing repayment options are often due at the end of the loan period and are very flexible.and require little due diligence. It is a cheaper easier way to secure capital fudning to get to a next phase of business development (ie. and acquire clinics for example... Which was already said here) without going to a bank. The shares are likely ... I'm guessing... part of the Mezzanine financing deal.
https://www.investopedia.com/terms/m/mezzaninefinancing.asp
Think about it. Buying into Impact at 25 cents per share and them buying a stock you have option for at 8 cents per share and the stock has been trading at a low of 5 cents since this all.happened. That's a lot of upside, especially when we know the stock is ready for uplist and that there are.profitable.companies like HRI which can be folded in and immediately make a 1.5 billion dollar valuation a reality which is about $3 a share on its own.
https://youtu.be/sd4dOiaTgD4
https://www.investopedia.com/ask/answers/0310...ctured.asp
What I'm saying is that I don't think we have anything to worry about in terms of the if. I believe based on above that the Mezzanine financing terms are based on or tied to the uplist. Therefore this has to happen as part of the loan repayment. And the indication from Impact is that this happens in Q1.
Finally, In terms of the exit for Mezzanine Financing (ie. How do the private lenders get paid back). It is often through IPO or through expected increased earnings. Oh and by the way, Mezzanine financing does not dilute shares and maintains shareholder equity.
Thanks Doc!
Ps. Remember I am a healthcare worker so thisn isnt my area of expertise. But I hope
... At the very least... this helps a bit and that the links are useful.
(22)
(0)